Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Needle Based Biopsy Gun Market

ID: MRFR/HC/36922-HCR
100 Pages
Nidhi Mandole
Last Updated: May 21, 2026
Needle-Based Biopsy Gun Market Research Report By Type (Fully Automatic Biopsy Guns, Semi-Automatic Biopsy Guns, Manual Biopsy Guns), By End Use (Hospitals, Diagnostic Laboratories, Research Institutions, Ambulatory Surgical Centers), By Product Configuration (Single Use, Reusable), By Needle Size (Fine Gauge, Medium Gauge, Large Gauge) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Billion)
      1. 4.1.1 Fully Automatic Biopsy Guns
      2. 4.1.2 Semi-Automatic Biopsy Guns
      3. 4.1.3 Manual Biopsy Guns
    2. 4.2 Healthcare, BY End-Use (USD Billion)
      1. 4.2.1 Hospitals
      2. 4.2.2 Diagnostic Laboratories
      3. 4.2.3 Research Institutions
      4. 4.2.4 Ambulatory Surgical Centers
    3. 4.3 Healthcare, BY Product Configuration (USD Billion)
      1. 4.3.1 Single-Use
      2. 4.3.2 Reusable
    4. 4.4 Healthcare, BY Needle Size (USD Billion)
      1. 4.4.1 Fine Gauge
      2. 4.4.2 Medium Gauge
      3. 4.4.3 Large Gauge
    5. 4.5 Healthcare, BY Region (USD Billion)
      1. 4.5.1 North America
        1. 4.5.1.1 US
        2. 4.5.1.2 Canada
      2. 4.5.2 Europe
        1. 4.5.2.1 Germany
        2. 4.5.2.2 UK
        3. 4.5.2.3 France
        4. 4.5.2.4 Russia
        5. 4.5.2.5 Italy
        6. 4.5.2.6 Spain
        7. 4.5.2.7 Rest of Europe
      3. 4.5.3 APAC
        1. 4.5.3.1 China
        2. 4.5.3.2 India
        3. 4.5.3.3 Japan
        4. 4.5.3.4 South Korea
        5. 4.5.3.5 Malaysia
        6. 4.5.3.6 Thailand
        7. 4.5.3.7 Indonesia
        8. 4.5.3.8 Rest of APAC
      4. 4.5.4 South America
        1. 4.5.4.1 Brazil
        2. 4.5.4.2 Mexico
        3. 4.5.4.3 Argentina
        4. 4.5.4.4 Rest of South America
      5. 4.5.5 MEA
        1. 4.5.5.1 GCC Countries
        2. 4.5.5.2 South Africa
        3. 4.5.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Becton Dickinson and Company (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific Corporation (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medtronic plc (IE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Hologic, Inc. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Cook Medical Incorporated (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Terumo Corporation (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Smith & Nephew plc (GB)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Stryker Corporation (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 C.R. Bard, Inc. (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY TYPE
    4. 6.4 US MARKET ANALYSIS BY END-USE
    5. 6.5 US MARKET ANALYSIS BY PRODUCT CONFIGURATION
    6. 6.6 US MARKET ANALYSIS BY NEEDLE SIZE
    7. 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. 6.8 CANADA MARKET ANALYSIS BY END-USE
    9. 6.9 CANADA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    10. 6.10 CANADA MARKET ANALYSIS BY NEEDLE SIZE
    11. 6.11 EUROPE MARKET ANALYSIS
    12. 6.12 GERMANY MARKET ANALYSIS BY TYPE
    13. 6.13 GERMANY MARKET ANALYSIS BY END-USE
    14. 6.14 GERMANY MARKET ANALYSIS BY PRODUCT CONFIGURATION
    15. 6.15 GERMANY MARKET ANALYSIS BY NEEDLE SIZE
    16. 6.16 UK MARKET ANALYSIS BY TYPE
    17. 6.17 UK MARKET ANALYSIS BY END-USE
    18. 6.18 UK MARKET ANALYSIS BY PRODUCT CONFIGURATION
    19. 6.19 UK MARKET ANALYSIS BY NEEDLE SIZE
    20. 6.20 FRANCE MARKET ANALYSIS BY TYPE
    21. 6.21 FRANCE MARKET ANALYSIS BY END-USE
    22. 6.22 FRANCE MARKET ANALYSIS BY PRODUCT CONFIGURATION
    23. 6.23 FRANCE MARKET ANALYSIS BY NEEDLE SIZE
    24. 6.24 RUSSIA MARKET ANALYSIS BY TYPE
    25. 6.25 RUSSIA MARKET ANALYSIS BY END-USE
    26. 6.26 RUSSIA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    27. 6.27 RUSSIA MARKET ANALYSIS BY NEEDLE SIZE
    28. 6.28 ITALY MARKET ANALYSIS BY TYPE
    29. 6.29 ITALY MARKET ANALYSIS BY END-USE
    30. 6.30 ITALY MARKET ANALYSIS BY PRODUCT CONFIGURATION
    31. 6.31 ITALY MARKET ANALYSIS BY NEEDLE SIZE
    32. 6.32 SPAIN MARKET ANALYSIS BY TYPE
    33. 6.33 SPAIN MARKET ANALYSIS BY END-USE
    34. 6.34 SPAIN MARKET ANALYSIS BY PRODUCT CONFIGURATION
    35. 6.35 SPAIN MARKET ANALYSIS BY NEEDLE SIZE
    36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
    37. 6.37 REST OF EUROPE MARKET ANALYSIS BY END-USE
    38. 6.38 REST OF EUROPE MARKET ANALYSIS BY PRODUCT CONFIGURATION
    39. 6.39 REST OF EUROPE MARKET ANALYSIS BY NEEDLE SIZE
    40. 6.40 APAC MARKET ANALYSIS
    41. 6.41 CHINA MARKET ANALYSIS BY TYPE
    42. 6.42 CHINA MARKET ANALYSIS BY END-USE
    43. 6.43 CHINA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    44. 6.44 CHINA MARKET ANALYSIS BY NEEDLE SIZE
    45. 6.45 INDIA MARKET ANALYSIS BY TYPE
    46. 6.46 INDIA MARKET ANALYSIS BY END-USE
    47. 6.47 INDIA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    48. 6.48 INDIA MARKET ANALYSIS BY NEEDLE SIZE
    49. 6.49 JAPAN MARKET ANALYSIS BY TYPE
    50. 6.50 JAPAN MARKET ANALYSIS BY END-USE
    51. 6.51 JAPAN MARKET ANALYSIS BY PRODUCT CONFIGURATION
    52. 6.52 JAPAN MARKET ANALYSIS BY NEEDLE SIZE
    53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
    54. 6.54 SOUTH KOREA MARKET ANALYSIS BY END-USE
    55. 6.55 SOUTH KOREA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    56. 6.56 SOUTH KOREA MARKET ANALYSIS BY NEEDLE SIZE
    57. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
    58. 6.58 MALAYSIA MARKET ANALYSIS BY END-USE
    59. 6.59 MALAYSIA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    60. 6.60 MALAYSIA MARKET ANALYSIS BY NEEDLE SIZE
    61. 6.61 THAILAND MARKET ANALYSIS BY TYPE
    62. 6.62 THAILAND MARKET ANALYSIS BY END-USE
    63. 6.63 THAILAND MARKET ANALYSIS BY PRODUCT CONFIGURATION
    64. 6.64 THAILAND MARKET ANALYSIS BY NEEDLE SIZE
    65. 6.65 INDONESIA MARKET ANALYSIS BY TYPE
    66. 6.66 INDONESIA MARKET ANALYSIS BY END-USE
    67. 6.67 INDONESIA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    68. 6.68 INDONESIA MARKET ANALYSIS BY NEEDLE SIZE
    69. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
    70. 6.70 REST OF APAC MARKET ANALYSIS BY END-USE
    71. 6.71 REST OF APAC MARKET ANALYSIS BY PRODUCT CONFIGURATION
    72. 6.72 REST OF APAC MARKET ANALYSIS BY NEEDLE SIZE
    73. 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. 6.74 BRAZIL MARKET ANALYSIS BY TYPE
    75. 6.75 BRAZIL MARKET ANALYSIS BY END-USE
    76. 6.76 BRAZIL MARKET ANALYSIS BY PRODUCT CONFIGURATION
    77. 6.77 BRAZIL MARKET ANALYSIS BY NEEDLE SIZE
    78. 6.78 MEXICO MARKET ANALYSIS BY TYPE
    79. 6.79 MEXICO MARKET ANALYSIS BY END-USE
    80. 6.80 MEXICO MARKET ANALYSIS BY PRODUCT CONFIGURATION
    81. 6.81 MEXICO MARKET ANALYSIS BY NEEDLE SIZE
    82. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
    83. 6.83 ARGENTINA MARKET ANALYSIS BY END-USE
    84. 6.84 ARGENTINA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    85. 6.85 ARGENTINA MARKET ANALYSIS BY NEEDLE SIZE
    86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
    88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEEDLE SIZE
    90. 6.90 MEA MARKET ANALYSIS
    91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END-USE
    93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT CONFIGURATION
    94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY NEEDLE SIZE
    95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END-USE
    97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY NEEDLE SIZE
    99. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
    100. 6.100 REST OF MEA MARKET ANALYSIS BY END-USE
    101. 6.101 REST OF MEA MARKET ANALYSIS BY PRODUCT CONFIGURATION
    102. 6.102 REST OF MEA MARKET ANALYSIS BY NEEDLE SIZE
    103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. 6.104 RESEARCH PROCESS OF MRFR
    105. 6.105 DRO ANALYSIS OF HEALTHCARE
    106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    110. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    111. 6.111 HEALTHCARE, BY END-USE, 2024 (% SHARE)
    112. 6.112 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
    113. 6.113 HEALTHCARE, BY PRODUCT CONFIGURATION, 2024 (% SHARE)
    114. 6.114 HEALTHCARE, BY PRODUCT CONFIGURATION, 2024 TO 2035 (USD Billion)
    115. 6.115 HEALTHCARE, BY NEEDLE SIZE, 2024 (% SHARE)
    116. 6.116 HEALTHCARE, BY NEEDLE SIZE, 2024 TO 2035 (USD Billion)
    117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.2.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.3.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.3.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.3.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.4.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.4.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.4.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.5.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.5.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.5.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.6.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.6.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.6.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.7.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.7.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.7.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.8.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.8.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.8.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.9.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.9.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.9.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.10.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.10.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.10.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.11.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.11.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.11.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.12.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.12.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.12.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.13.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.13.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.13.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.14.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.14.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.14.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.15.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.15.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.15.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.16.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.16.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.16.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.17.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.17.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.17.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.18.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.18.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.18.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.19.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.19.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.19.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.20.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.20.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.20.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.21.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.21.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.21.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.22.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.22.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.22.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.23.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.23.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.23.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.24.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.24.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.24.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.25.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.25.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.25.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.26.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.26.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.26.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.27.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.27.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.27.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.28.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.28.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.28.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.29.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.29.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.29.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.30.2 BY END-USE, 2025-2035 (USD Billion)
      3. 7.30.3 BY PRODUCT CONFIGURATION, 2025-2035 (USD Billion)
      4. 7.30.4 BY NEEDLE SIZE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Fully Automatic Biopsy Guns
  • Semi-Automatic Biopsy Guns
  • Manual Biopsy Guns

Healthcare By End-Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Ambulatory Surgical Centers

Healthcare By Product Configuration (USD Billion, 2025-2035)

  • Single-Use
  • Reusable

Healthcare By Needle Size (USD Billion, 2025-2035)

  • Fine Gauge
  • Medium Gauge
  • Large Gauge